Safety Assessment in the Development of Novel Chemotherapeutics

  • Morse, David E.

  • Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, FDA, Rockville, Maryland 20857

Toxicologic Pathology 31(3):p 156, January 2003.
Copyright ©2003Sage Publications